A groundbreaking new study by Queen Mary University and King's College London is set to shed light on a previously under-researched area: the potential link between Attention Deficit Hyperactivity Disorder (ADHD) symptoms and hormonal fluctuations during the menstrual cycle. Many women living with ADHD have reported that their symptoms, which can include difficulties with concentration, emotional regulation, and restlessness, appear to worsen during specific phases of their cycle.
The study, described as a first of its kind, is actively recruiting approximately 50 women who have been diagnosed with ADHD and are currently receiving medication for the condition. Participants are being asked to meticulously track their menstrual cycles and document any changes they observe in their ADHD symptoms, as well as the broader impact these changes have on their daily lives.
Dr. Jessica Agnew-Blais, the lead academic overseeing this significant research, highlighted the motivation behind the study. She explained that historical research into ADHD has predominantly focused on men and boys, leading to a notable gap in understanding how the condition manifests and is affected in women. This new investigation aims to correct that imbalance and provide crucial insights into the female experience of ADHD.
The findings from this study could have substantial implications for the diagnosis and management of ADHD in women across the UK. Understanding the interplay between hormonal changes and ADHD symptoms could lead to more personalised treatment plans and support strategies, potentially improving the quality of life for many individuals.
While this is an initial study, its findings are expected to contribute significantly to the broader scientific understanding of ADHD, particularly concerning its presentation in women. The research will hopefully pave the way for further investigations into how biological factors, such as hormonal cycles, interact with neurological conditions like ADHD.